Companies spend more than $125MM over 3 years leading up to a launch and $10MM in internal headcount. Rising costs and industry pressures now require a more advanced commercialization model to ensure long-term commercial success and sustainable value for key stakeholders.
From industry-leading patient services and adherence solutions to global pricing and revenue management, EVERSANA’s end-to-end commercialization strategy increases speed to market and accelerates growth for pharmaceutical, medical device, and digital therapies.
EVERSANA’s comprehensive suite of commercial services powered by Data & Analytics help navigate product launches in this new era with confidence:
Imagine not having to risk building an expensive infrastructure – because we have built a foundation you can customize for your product needs. Activate a complete, ready-to-deploy, high-performance commercialization and distribution engine today!
Or use our solutions to optimize your launch and achieve your commercial goals
The intelligence you need to validate or inform your strategy across the product life cycle.了解更多
Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.了解更多
Assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.了解更多
Agile, all-inclusive supply chain model proven to maximize profits.了解更多
Automated Processes Reduce Access Barriers & Simplify Onboarding了解更多
Strategies to support global launches and address complexities across markets.了解更多
How do you successfully commercialize a new product in the new era of “patient-as-consumer” and “outcomes-based healthcare”?
You design and deliver an engaging, high-touch patient experience.
In this 30-minute webinar, Tom Doyle explains how manufacturers need to develop cohesive strategies that target all stakeholders who influence the patient experience. In doing so, patient support programs:
Watch the webinar to learn more about developing patient-centric patient support programs proven to evolve throughout the product life cycle.